Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Synthetic Vaccine Against P. falciparum Malaria

Posted Feb 27 2011 7:00pm

Description of Invention:
A synthetic vaccine is available for testing against P. falciparum malaria. Control of malarial disease has been achieved on a limited basis in certain parts of the world; however, no vaccine presently exists that can provide protective immunity. This synthetic vaccine contains a peptide which induces the activation of cytotoxic T cells that specifically recognize and kill cells infected with malaria sporozoites.

Inventors:
Michael F Good (NIAID)


Patent Status:
HHS, Reference No. E-226-1988/0
PCT, Application No. PCT/US89/02921 filed 03 Jul 1989



Portfolios:
Infectious Diseases
Infectious Diseases - Vaccines



For Licensing Information Please Contact:
Admin. Licensing Spec-InfectDis
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: anos@mail.nih.gov
Phone: 301-496-7057
Fax: 301-402-0220


Ref No: 1188

Updated: 02/2011

Post a comment
Write a comment:

Related Searches